Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Oral Allergy Syndrome

ClinicalTrials.gov lists 2 trials for Oral Allergy Syndrome or a narrower condition beneath it.

MeSH D000099072 Immune System Diseases C20
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Phase 4 Phase 4 1 Not applicable Not applicable 1 Phase 4 Phase 4 1 Not applicable Not applicable 1

Trials per phase

2 of the 2 trials are tagged with Oral Allergy Syndrome itself; the rest are tagged with a narrower condition beneath it.

Get the Oral Allergy Syndrome report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Oral Allergy Syndrome trials start? (2)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials started per year
Year Trials started
2013 1
2012 1

No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: none of the 2 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Oral Allergy Syndrome trials in? (2)

Shown in this order: phase order.

Show the trials by phase as a table
Trials by phase
Phase Trials
Phase 4 1
Not applicable 1

How many Oral Allergy Syndrome trials are recruiting? (2)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Completed 1
Unknown status 1

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, publications, prevalence, rare-disease identity, and sub-conditions in mesh.

Not computed for conditions with fewer than 10 trials: drugs tested.

Browse all condition evidence pages